UPDATE: Oppenheimer Starts Pliant Therapeutics (PLRX) at Outperform
Tweet Send to a Friend
(Updated - December 9, 2021 4:12 PM EST)
Oppenheimer analyst Jeff Jones initiates coverage on Pliant Therapeutics (NASDAQ: PLRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones initiates coverage on Pliant Therapeutics (NASDAQ: PLRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
